A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

New England Journal of Medicine

Volumn 340, Issue 9, 1999, Pages 685-691

  Jorenby, Douglas E ^a,f   Leischow, Scott J ^b   Nides, Mitchell A ^c   Rennard, Stephen I ^d   Johnston, J Andrew ^e   Hughes, Arlene R ^e   Smith, Stevens S ^a   Muramoto, Myra L ^b   Daughton, David M ^d   Doan, Kimberli ^c   Fiore, Michael C ^a   Baker, Timothy B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Los Angeles Clinical Trials   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e GLAXOSMITHKLINE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NICOTINE; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; WEIGHT GAIN;

EID: 0033522206     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199903043400903     Document Type: Article

References (25)

1. Smoking cessation during previous year among adults - United States, 1990 and 1991. MMWR Morb Mortal Wkly Rep 1993;42:504-7.
2. Fiore MC, Bailey WC, Cohen SC, et al. Smoking cessation. Clinical practice guideline no. 18. Rockville, Md.: Agency for Health Care Policy and Research, April 1996. (AHCPR publication no. 96-0692.)
3. Baker TB, Morse E, Sherman JE. The motivation to use drugs: a psychobiological analysis of urges. In: Rivers C, ed. Nebraska symposium on motivation. Vol. 34. Alcohol use and abuse. Lincoln: University of Nebraska Press, 1987.
4. Brandon TH. Negative affect as motivation to smoke. Curr Dir Psychol Sci 1994;3:33-7.
5. Hall SM, Munoz RF, Reus VI, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol 1996;64:1003-9.
6. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking: a national perspective. JAMA 1990;264:1541-5.
7. Glassman AH, Covey LS. Smoking and affective disorder. Am J Health Behav 1996;20:279-85.
8. Kandel DB, Davies M. Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry 198a;43.255-62.
9. Lipkus IM, Barefoot JC, Williams RB, Siegler IC. Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study. Health Psychol 1994;13:149-55.
10. Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996;379:733-6.
11. Fern LH, Burchette RJ. Efficacy of bupropion for smoking cessation in non-depressed smokers. J Addict Dis 1994;13:249.
12. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337:1195-202.
13. Ascher JA, Cole JO, Colin JN, et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401.
14. Beck AT, Steer RA. Beck Depression Inventory. Philadelphia: Center for Cognitive Therapy, 1978.
15. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978;3:235-41.
16. SAS/STAT user's guide, version 6. 4th ed. Cary, N.C.: SAS Institute, 1990.
17. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
18. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.
19. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986;43:289-94.
20. Department of Health and Human Services. COSTART: coding symbols for thesaurus of adverse reaction terms. 3rd ed. Rockville, Md.: Food and Drug Administration, 1989.
21. Jorenby DE, Hatsukami DK, Smith SS, et al. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology (Berl) 1996;128:130-8.
22. Leischow SJ, Sachs DPL, Bostrom AG, Hansen MD. Effects of differing nicotine replacement doses on weight gain after smoking cessation. Arch Fam Med 1992;1:233-7.
23. Nides M, Rand C, Dolce J, et al. Weight gain as a function of smoking cessation and 2-mg nicotine gum use among middle-aged smokers with mild lung impairment in the first 2 years of the Lung Health Study. Health Psychol 1994;13:354-61.
24. Hughes JR. Tobacco withdrawal in self-quitters. J Consult Clin Psychol 1992;60:689-97.
25. Fagerstrom KO. Combined use of nicotine replacement products. Health Values 1994;18:15-20.